Articles | Open Access | https://doi.org/10.55640/

ANALYSIS OF CYTOCHEMICAL CHARACTERISTICS OF PERIPHERAL BLOOD MONOCYTES IN COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN UNDER ONE YEAR OF AGE WITH CONGENITAL HEART DEFECTS

Mukhammadkhonov Abdulfaizkhon Shamsuddinkhon ugli , Propaedeutics of children's diseases and polyclinic pediatrics, Andijan State Medical Institute

Abstract

Community-acquired pneumonia (CAP) remains a leading cause of morbidity in infants, particularly when complicated by comorbid conditions such as congenital heart defects (CHD). The hemodynamic disturbances associated with CHD create a unique pathological environment that alters the immune response at the cellular level. This article presents a study conducted jointly by Tashkent State Medical University and Andijan State Medical Institute. Using the IMRAD framework, the research investigates the metabolic activity of peripheral blood monocytes by analyzing key enzymes: succinate dehydrogenase (SDH), acid phosphatase (AP), and myeloperoxidase (MPO). The study involved 58 children aged 6 months to 3 years, stratified by the presence of CHD and the severity of pneumonia. The results demonstrate that children with CHD exhibit profound metabolic suppression in immune cells, characterized by significantly reduced SDH activity and elevated lysosomal enzyme activity (AP) during the acute phase. The study concludes that cytochemical monitoring of monocytes provides a sensitive marker for assessing the severity of metabolic disturbances and predicting the clinical course of pneumonia in children with cardiac anomalies.

Keywords

community-acquired pneumonia, congenital heart defects, monocytes, cytochemistry, succinate dehydrogenase, acid phosphatase, myeloperoxidase, infants.

References

Skvortsov, V. V., Tumarenko, A. V., & Baimankulov, S. S. (2017). Etiology, approaches to diagnosis and therapy of congenital heart disease. Actual Theme Journal, 7, 14-17.

Akhmedova, D. I., & Sotvoldiva, M. S. (2024). Congenital heart defects in children: prevalence, risk factors, principles of prevention and screening. International Journal of Scientific Pediatrics, 3, 463-473. doi:10.56121/2181-2926-2024-3-1463-474

Karimdzhanov, I. A., Gazieva, A. S., & Togaev, M. K. (2023). Community-acquired pneumonia in children (literature review). Eurasian Journal of Medical and Natural Sciences, 3(1), 34–41.

Tatochenko, V. K. (2021). Community-acquired pneumonia in children - problems and solutions. Russian Bulletin of Perinatology and Pediatrics, 66(1), 9-11.

Teselkin, E. V., Lavrenova, D. S., & Krivitskaya, L. V. (2023). Pneumonia in children of the first year of life. Vestnik Nauki, 1(58), 2, 297–302.

Metlay, J., Waterer, G., Long, A., et al. (2019). Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Critical Care Med, 200(7), e45–e64.

World Health Organization. (2014). WHO’s first global report on antibiotic resistance reveals serious, worldwide threat to public health. WHO.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

ANALYSIS OF CYTOCHEMICAL CHARACTERISTICS OF PERIPHERAL BLOOD MONOCYTES IN COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN UNDER ONE YEAR OF AGE WITH CONGENITAL HEART DEFECTS. (2026). International Journal of Medical Sciences, 6(02), 122-126. https://doi.org/10.55640/